IN2006CH01264A - - Google Patents

Info

Publication number
IN2006CH01264A
IN2006CH01264A IN1264CH2006A IN2006CH01264A IN 2006CH01264 A IN2006CH01264 A IN 2006CH01264A IN 1264CH2006 A IN1264CH2006 A IN 1264CH2006A IN 2006CH01264 A IN2006CH01264 A IN 2006CH01264A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Nobukazu Tanaka
Yoshiro Nagai
Hiroshi Kawaguchi
Tadashi Fukami
Terumasa Hosokawa
Original Assignee
Fuji Chem Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Chem Ind Co Ltd filed Critical Fuji Chem Ind Co Ltd
Publication of IN2006CH01264A publication Critical patent/IN2006CH01264A/en
Publication of IN230659B publication Critical patent/IN230659B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1264CH2006 2003-10-15 2004-09-21 IN230659B (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003355076 2003-10-15
JP2004236573A JP3841804B2 (ja) 2003-10-15 2004-08-16 口腔内速崩壊性錠剤用の組成物

Publications (2)

Publication Number Publication Date
IN2006CH01264A true IN2006CH01264A (xx) 2007-06-29
IN230659B IN230659B (xx) 2009-03-27

Family

ID=34380419

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1264CH2006 IN230659B (xx) 2003-10-15 2004-09-21

Country Status (7)

Country Link
US (1) US7838033B2 (xx)
EP (1) EP1523974B1 (xx)
JP (1) JP3841804B2 (xx)
KR (1) KR101119850B1 (xx)
ES (1) ES2694498T3 (xx)
IN (1) IN230659B (xx)
WO (1) WO2005037319A1 (xx)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US8349361B2 (en) * 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
IN234086B (xx) * 2003-10-15 2009-05-29 Fuji Chem Ind Co Ltd
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
IL169678A (en) 2005-07-14 2010-11-30 Innova Sa Sweetener compositions
CA2618977C (en) 2005-08-10 2014-10-21 Shionogi & Co., Ltd. Orally disintegratable tablet
JP4965096B2 (ja) * 2005-08-19 2012-07-04 テバ製薬株式会社 圧縮成型製剤
WO2007029376A1 (ja) * 2005-09-02 2007-03-15 Fuji Chemical Industry Co., Ltd. 口腔内速崩壊性錠剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
EP2001450B1 (en) 2006-03-31 2019-01-30 Rubicon Research Private Limited Directly compressible composite for orally disintegrating tablets
LT3103448T (lt) * 2006-09-26 2019-10-10 Novartis Ag Farmacinės kompozicijos, apimančios s1p moduliatorių
WO2008079342A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets
EP2101739A2 (en) * 2006-12-21 2009-09-23 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
UY31411A1 (es) * 2007-10-30 2009-05-29 Composicion orodispersable sin mal olor o mal sabor que comprende acidos grasos poliinsaturados
WO2009107864A2 (en) * 2008-02-29 2009-09-03 Otsuka Pharmaceutical Co., Ltd. An orally disintegrating tablet
JP5572321B2 (ja) * 2008-03-07 2014-08-13 沢井製薬株式会社 被覆微粒子含有口腔内崩壊錠
KR101046789B1 (ko) * 2008-07-16 2011-07-05 동아제약주식회사 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
MX2011005167A (es) * 2008-11-20 2011-05-30 Avantor Performance Mat Inc Excipiente co-procesado basado en fosfato dibasico de calcio, granular, de alta funcionalidad, directamente compresible.
JP4329947B1 (ja) 2009-01-20 2009-09-09 ライオン株式会社 内服用錠剤
JP5637624B2 (ja) 2009-02-12 2014-12-10 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
WO2010104563A2 (en) 2009-03-09 2010-09-16 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
US20120178822A1 (en) * 2009-04-28 2012-07-12 Isp Investments Inc. Co-Processed Excipient Compositions
US20100285164A1 (en) * 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
CN102458475B (zh) 2009-05-20 2016-03-30 大日本住友制药株式会社 压制包衣的口腔崩解片
US20110097401A1 (en) * 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
JP5835875B2 (ja) * 2009-06-29 2015-12-24 富士化学工業株式会社 口腔内速崩壊錠の製造方法
JP5674666B2 (ja) * 2009-08-11 2015-02-25 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
US8591955B2 (en) 2009-08-11 2013-11-26 Dainippon Sumitomo Pharma Co., Ltd. Orally rapidly disintegrating tablet that contains two or more types of particles
WO2011019046A1 (ja) 2009-08-11 2011-02-17 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
TWI461213B (zh) 2009-11-05 2014-11-21 Fmc Corp 作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物
WO2012085043A2 (en) 2010-12-22 2012-06-28 Basf Se Rapidly disintegrating, solid coated dosage form
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
WO2013161823A1 (ja) * 2012-04-24 2013-10-31 第一三共株式会社 口腔内崩壊錠及びその製造方法
WO2014014010A1 (ja) 2012-07-20 2014-01-23 大塚製薬株式会社 表面にインクの乾燥皮膜を有する錠剤、及びインクジェットプリンタ用インク
FR2999432B1 (fr) * 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
US20160136091A1 (en) * 2013-07-19 2016-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Orally Disintegrating Tablet
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
JP6154019B2 (ja) * 2013-10-07 2017-06-28 富士フイルム株式会社 口腔内崩壊錠
US10207004B2 (en) 2014-04-04 2019-02-19 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US20160242439A1 (en) 2014-04-04 2016-08-25 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US10231476B2 (en) 2014-04-04 2019-03-19 Douxmatok Ltd Sweetener compositions and foods, beverages, and consumable products made thereof
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
UA123098C2 (uk) 2015-06-18 2021-02-17 Естетра Спрл Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
PE20231714A1 (es) 2015-06-18 2023-10-23 Estetra Sprl Unidad de dosificacion orodispersable que contiene un componente estetrol
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
TWI801561B (zh) * 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN110237261A (zh) * 2019-07-30 2019-09-17 珠海市东辰制药有限公司 一种复合崩解剂及其制备方法
CN110840855B (zh) * 2019-11-27 2022-04-12 哈尔滨珍宝制药有限公司 依托考昔片及其制备方法
JPWO2022210829A1 (xx) * 2021-04-01 2022-10-06

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US75437A (en) * 1868-03-10 Improvement in steaw-cutters
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
DE59400446D1 (de) * 1993-04-15 1996-08-29 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
IL110376A (en) 1993-08-02 1998-08-16 Bristol Myers Squibb Co Pharmaceutical preparations containing iftroban and methods for their preparation
NZ278678A (en) 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
EP0826376B1 (en) * 1995-05-02 2007-01-24 Taisho Pharmaceutical Co. Ltd Composition for oral administration
JP2003176242A (ja) 1996-07-12 2003-06-24 Dai Ichi Seiyaku Co Ltd 速崩壊性圧縮成型物及びその製造法
JP3961596B2 (ja) 1996-10-15 2007-08-22 富士化学工業株式会社 無機制酸剤含有速分散性造粒物、その製造方法及び用時懸濁内服制酸剤
JPH11302157A (ja) 1998-04-17 1999-11-02 Eisai Co Ltd 口腔内速崩壊性錠剤
TW499394B (en) 1998-04-24 2002-08-21 Fuji Chem Ind Co Ltd A saccaride-containing cpmposition
US20010023252A1 (en) * 1998-07-02 2001-09-20 Smithkline Beecham Plc Novel compound
JP2000086537A (ja) 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
KR20010006835A (ko) * 1999-03-25 2001-01-26 김선진 경구용 속붕해정
WO2000057857A1 (en) 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
CA2374760A1 (en) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
JP4588818B2 (ja) 1999-09-16 2010-12-01 日本化学機械製造株式会社 錠剤用賦形剤及び錠剤
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US20020076437A1 (en) 2000-04-12 2002-06-20 Sanjeev Kothari Flashmelt oral dosage formulation
US6316029B1 (en) 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
JP2002128661A (ja) * 2000-10-20 2002-05-09 Chugai Pharmaceut Co Ltd 速崩壊錠剤の製造方法
JP2002154948A (ja) * 2000-11-22 2002-05-28 Eisai Co Ltd 崩壊性に優れた錠剤
CA2440361A1 (en) 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co. Ltd. Intraorally rapidly disintegrable preparation
AU2002316020B2 (en) 2001-07-16 2007-03-15 Astrazeneca Ab Pharmaceutical formulation comprising a proton pump inhibitor and antacids
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
CN1638803A (zh) 2002-03-06 2005-07-13 协和发酵工业株式会社 口腔内速崩解性片剂

Also Published As

Publication number Publication date
EP1523974A1 (en) 2005-04-20
IN230659B (xx) 2009-03-27
US20050106240A1 (en) 2005-05-19
US7838033B2 (en) 2010-11-23
ES2694498T3 (es) 2018-12-21
EP1523974B1 (en) 2018-08-08
KR101119850B1 (ko) 2012-02-28
JP3841804B2 (ja) 2006-11-08
WO2005037319A1 (ja) 2005-04-28
KR20070018777A (ko) 2007-02-14
JP2005139168A (ja) 2005-06-02

Similar Documents

Publication Publication Date Title
BE2015C007I2 (xx)
BE2014C055I2 (xx)
BE2014C027I2 (xx)
BE2013C075I2 (xx)
BE2013C069I2 (xx)
BE2013C067I2 (xx)
BE2013C038I2 (xx)
BE2013C036I2 (xx)
BE2011C030I2 (xx)
IN2006CH01264A (xx)
IN2006CH01274A (xx)
BE2015C005I2 (xx)
BE2012C053I2 (xx)
AU2002321535A1 (xx)
AU2002324323A1 (xx)
AU2002329412A1 (xx)
AU2002327042A1 (xx)
AU2002332887A1 (xx)
AU2002333044A1 (xx)
AU2002337949A1 (xx)
AU2003207787A1 (xx)
AU2002322913A1 (xx)
AU2002348177A1 (xx)
AU2002351829A1 (xx)
AU2002353888A1 (xx)